State-of-the-Art Review: Analysis of Individual Heart Failure Risk Factors in Diabetes Elucidates Role of SGLT2 Inhibition
Sodium-glucose cotransporter 2 (SGLT2) inhibitors may mitigate each of the mechanisms of heart failure in diabetics; these mechanisms are probably mediated through hyperinsulinemia for those with type 2 disease, according to a new state-of-the-art review.